Physician profile
John Leogite
NPI 1740655216
$4,109.66
in general payments reported to CMS, 2019-2025
10 companies · $2,704 in 2025
The $2,704 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,036 · 2024: $370 · 2025: $2,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,393 · Travel and Lodging: $1,716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,393.25 |
| Travel and Lodging | $1,716.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,685.50 | 2025 | |
| Urgo Medical North America, LLC | $952.22 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Kci USA, INC. | $939.75 | 2023 | 3m Coban, Snap, V.A.C. Dermatac |
| Solventum Corporation | $199.71 | 2024-2025 | Activ.A.C., Promogran Prisma, Snap |
| Smith+Nephew, INC. | $142.27 | 2025 | Collagenase Santyl, Grafix, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Paratek Pharmaceuticals, INC. | $113.71 | 2024-2025 | Nuzyra |
| Integra Lifesciences Corporation | $23.24 | 2023 | Tcc-Ez |
| Organogenesis INC. | $18.53 | 2024 | |
| Boston Scientific Corporation | $18.09 | 2024 | Sentinel |
| Abbvie INC. | $16.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Leogite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.